co-presented by
ASSOCIATE SPONSORS
co-presented by
ASSOCIATE SPONSORS
The Metro Man of India, Elattuvalapil Sreedharan, now 92, is credited with changing the face of public transport in India with his leadership in building the Konkan Railway and the Delhi Metro. He is also a Padma Shri and a Padma Vibhushan awardee.
New-age players, in spite of cutting down on discounts, are seeing significantly higher revenue growth than incumbents.
Discount-centric strategies, favoured by some of the Tata 1mg’s rivals, are unsustainable in the long term, co-founder Gaurav Agarwal said
Analysts said the race to the bottom seems to be over and there appears to be a clear shift in the sector, with prices increasing gradually
Most new-age diagnostic players moved away from heavy discounts and are now raising prices. With this, the difference in pricing between incumbents and established players is narrowing and moving towards a level-playing field
The venture fund said it plans to make follow-on investments exclusively into companies of previous funds, as co-investors with growth-stage funds in Series B, C and D rounds.
The healthcare startup's losses widened at a time when it is putting itself on a path to profitability and is hopeful of turning profits in the next two years. Its losses increased primarily on the back of mounting expenses in FY23
Polycystic ovary syndrome is a common endocrine disorder predominantly affecting women of reproductive age. Clinical manifestations are diverse, including overproduction of some male hormones, lack of ovulation, infertility, hair loss and increased risk of metabolic diseases, besides psychosocial dysfunction
We expect an earnings CAGR in mid-teens in the medium term for VDC on the back of an expansion-led volume growth in the hinterland
The premium was over 5x of 1mg's previous fundraise, which had valued the startup at $240 million. The latest round values Tata 1mg between $1.25 and $1.30 billion
